These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25042996)

  • 1. Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.
    Steyerberg EW; Vedder MM; Leening MJ; Postmus D; D'Agostino RB; Van Calster B; Pencina MJ
    Biom J; 2015 Jul; 57(4):556-70. PubMed ID: 25042996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity and specificity can change in opposite directions when new predictive markers are added to risk models.
    Van Calster B; Steyerberg EW; D'Agostino RB; Pencina MJ
    Med Decis Making; 2014 May; 34(4):513-22. PubMed ID: 24378915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].
    Steyerberg EW; Pencina MJ; Van Calster B
    Ned Tijdschr Geneeskd; 2012; 156(41):A5029. PubMed ID: 23062255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance measures for prediction models and markers: evaluation of predictions and classifications].
    Steyerberg EW; Van Calster B; Pencina MJ
    Rev Esp Cardiol; 2011 Sep; 64(9):788-94. PubMed ID: 21763052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating a new marker for risk prediction: decision analysis to the rescue.
    Baker SG; Kramer BS
    Discov Med; 2012 Sep; 14(76):181-8. PubMed ID: 23021372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the incremental value of diagnostic and prognostic markers: a review and illustration.
    Steyerberg EW; Pencina MJ; Lingsma HF; Kattan MW; Vickers AJ; Van Calster B
    Eur J Clin Invest; 2012 Feb; 42(2):216-28. PubMed ID: 21726217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the weighted area under the net benefit curve for decision curve analysis.
    Talluri R; Shete S
    BMC Med Inform Decis Mak; 2016 Jul; 16():94. PubMed ID: 27431531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.
    Pencina MJ; D'Agostino RB; D'Agostino RB; Vasan RS
    Stat Med; 2008 Jan; 27(2):157-72; discussion 207-12. PubMed ID: 17569110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Net reclassification index at event rate: properties and relationships.
    Pencina MJ; Steyerberg EW; D'Agostino RB
    Stat Med; 2017 Dec; 36(28):4455-4467. PubMed ID: 27426413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What to expect from net reclassification improvement with three categories.
    Pencina KM; Pencina MJ; D'Agostino RB
    Stat Med; 2014 Dec; 33(28):4975-87. PubMed ID: 25176621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.
    Van Calster B; Vickers AJ; Pencina MJ; Baker SG; Timmerman D; Steyerberg EW
    Med Decis Making; 2013 May; 33(4):490-501. PubMed ID: 23313931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A program for computing the prediction probability and the related receiver operating characteristic graph.
    Jordan D; Steiner M; Kochs EF; Schneider G
    Anesth Analg; 2010 Dec; 111(6):1416-21. PubMed ID: 21059744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease.
    Weijmans M; de Bakker PI; van der Graaf Y; Asselbergs FW; Algra A; Jan de Borst G; Spiering W; Visseren FL;
    Atherosclerosis; 2015 Apr; 239(2):451-8. PubMed ID: 25687271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.
    Leening MJ; Vedder MM; Witteman JC; Pencina MJ; Steyerberg EW
    Ann Intern Med; 2014 Jan; 160(2):122-31. PubMed ID: 24592497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular hypertrophy and risk reclassification for coronary events in multi-ethnic adults.
    Zalawadiya SK; Gunasekaran PC; Bavishi CP; Veeranna V; Panaich S; Afonso L
    Eur J Prev Cardiol; 2015 May; 22(5):673-9. PubMed ID: 24699336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk.
    Bell K; Hayen A; McGeechan K; Neal B; Irwig L
    Eur J Prev Cardiol; 2012 Dec; 19(6):1474-85. PubMed ID: 21947629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.
    Merry AH; Boer JM; Schouten LJ; Ambergen T; Steyerberg EW; Feskens EJ; Verschuren WM; Gorgels AP; van den Brandt PA
    Eur J Prev Cardiol; 2012 Aug; 19(4):840-8. PubMed ID: 21551214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New metrics for assessing diagnostic potential of candidate biomarkers.
    Pickering JW; Endre ZH
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1355-64. PubMed ID: 22679181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of risk prediction by genomic profiling: reclassification measures versus the area under the receiver operating characteristic curve.
    Mihaescu R; van Zitteren M; van Hoek M; Sijbrands EJ; Uitterlinden AG; Witteman JC; Hofman A; Hunink MG; van Duijn CM; Janssens AC
    Am J Epidemiol; 2010 Aug; 172(3):353-61. PubMed ID: 20562194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.